Related Experiment Video

Updated: Aug 6, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Targeting the double-strand DNA break repair pathway as a therapeutic strategy

Christopher J Lord1, Michelle D Garrett, Alan Ashworth

  • 1The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|August 11, 2006
PubMed

Insights

DNA repair pathways maintain genome integrity. Targeting DNA double-strand break (DSB) repair mechanisms offers potential cancer therapies by sensitizing tumor cells to DNA-damaging agents.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA repair pathways are essential for preserving genome stability.
  • DNA double-strand breaks (DSB) trigger complex signaling and repair mechanisms.
  • Tumor cells often exhibit specific DNA repair defects, presenting therapeutic vulnerabilities.

Purpose of the Study:

  • To review the mechanisms of DSB repair.
  • To explore therapeutic strategies targeting DSB repair pathways.
  • To discuss the potential of synthetic lethal approaches in cancer treatment.

Main Methods:

  • Literature review of DNA repair mechanisms.
  • Analysis of signaling and repair components in DSB repair.
  • Discussion of therapeutic targeting strategies.

Main Results:

  • DSB repair involves intricate signaling and direct repair processes.
  • Inhibiting DSB repair components can sensitize cancer cells to DNA-damaging agents.
  • Exploiting tumor-specific DSB repair defects offers a "synthetic lethal" therapeutic rationale.

Conclusions:

  • Understanding DSB repair mechanisms is key to developing novel cancer therapies.
  • Targeting DSB repair pathways holds promise for enhancing the efficacy of existing treatments.
  • Synthetic lethality represents a promising strategy for precision oncology by exploiting cancer-specific vulnerabilities.

More Related Videos

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter06:59

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter

Published on: March 31, 2022

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy08:31

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy

Published on: June 8, 2018

Related Concept Videos

Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...